Published in AIDS on March 10, 2000
Evaluation of HepCure Toolkit to Improve Harvoni Adherence | NCT02740556
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med (2006) 8.57
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav (2006) 8.11
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (2004) 5.04
Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr (2006) 4.49
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr (2006) 3.93
Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr (2009) 3.88
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis (2011) 3.63
Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr (2011) 3.54
Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav (2009) 3.39
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26
Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis (2007) 3.16
Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav (2010) 3.08
Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc (2013) 3.00
Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav (2007) 2.98
Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med (2008) 2.97
Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83
Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol (2007) 2.62
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med (2013) 2.44
Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One (2008) 2.41
Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr (2008) 2.38
Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol (2003) 2.32
Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health (2007) 2.29
Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One (2010) 2.24
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav (2007) 2.20
Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care (2009) 2.18
Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med (2013) 2.16
Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med (2007) 2.15
Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform (2012) 2.14
A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol (2006) 2.08
Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. J Acquir Immune Defic Syndr (2010) 2.05
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS (2008) 2.02
Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials (2008) 2.01
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS (2009) 1.95
Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr (2007) 1.91
Prevention and treatment of hepatitis C in injection drug users. Hepatology (2002) 1.88
A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr (2006) 1.85
Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLoS One (2010) 1.79
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One (2009) 1.72
Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One (2012) 1.72
Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses (2013) 1.67
HIV infection in the elderly. Clin Interv Aging (2008) 1.59
Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med (2002) 1.58
Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr (2004) 1.56
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Arch Intern Med (2009) 1.54
Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med (2010) 1.54
Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav (2010) 1.53
Antiretrovirals and safer conception for HIV-serodiscordant couples. Curr Opin HIV AIDS (2012) 1.51
The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care (2007) 1.48
Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care (2010) 1.47
Helping the urban poor stay with antiretroviral HIV drug therapy. Am J Public Health (2000) 1.45
Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care (2008) 1.44
Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. PLoS One (2012) 1.44
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One (2011) 1.43
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy. AIDS Care (2006) 1.39
Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. J Health Psychol (2007) 1.38
Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav (2012) 1.38
Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr (2010) 1.38
A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep (2012) 1.37
Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. Int Health (2011) 1.37
Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. J Virol (2002) 1.35
Adherence to antiretroviral therapy for pediatric HIV infection: review of the literature and recommendations for research. Clin Child Fam Psychol Rev (2003) 1.35
Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav (2011) 1.35
Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses (2010) 1.35
Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav (2008) 1.35
Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr (2007) 1.34
Spending more to save more: interventions to promote adherence. Ann Intern Med (2010) 1.34
Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care (2008) 1.34
Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection. Milbank Q (2013) 1.33
Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS (2011) 1.33
A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med (2011) 1.33
Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One (2011) 1.30
Highly active antiretroviral therapy use and HIV transmission risk behaviors among individuals who are HIV infected and were recently released from jail. Am J Public Health (2008) 1.27
Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial. J Infect Dis (2012) 1.25
How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clin Trials (2008) 1.25
Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV? Behav Ther (2007) 1.25
Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study. AIDS Patient Care STDS (2011) 1.24
Prevalence and drivers of HIV stigma among health providers in urban India: implications for interventions. J Int AIDS Soc (2013) 1.24
Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr (2006) 1.24
Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep (2014) 1.23
Adherence discourse among African-American women taking HAART. AIDS Care (2002) 1.22
Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care (2012) 1.21
Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting. AIDS Behav (2011) 1.21
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial. AIDS (2010) 1.20
Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals. Telemed J E Health (2010) 1.20
Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS (2009) 1.19
Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health (2012) 1.18
Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir. Antimicrob Agents Chemother (2004) 1.17
Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. J Gen Intern Med (2004) 1.16
The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med (2009) 1.14
MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials (2012) 1.14
Comparison of antiretroviral adherence questions. AIDS Behav (2012) 1.14
Enhancing psychosocial support for HIV positive adolescents in Harare, Zimbabwe. PLoS One (2013) 1.14
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Socioeconomic status and health. The challenge of the gradient. Am Psychol (1994) 13.59
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA (1998) 9.32
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89
Socioeconomic inequalities in health. No easy solution. JAMA (1993) 7.11
HIV viral load markers in clinical practice. Nat Med (1996) 4.78
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med (2001) 4.42
HIV-1 protease inhibitors. A review for clinicians. JAMA (1997) 4.34
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med (1998) 3.81
Cooperation, control, and concession in meerkat groups. Science (2001) 3.79
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med (2001) 3.74
Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther (1988) 3.05
Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA (1993) 2.93
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis (2006) 2.83
Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med (1995) 2.63
Protease inhibitors in the homeless. JAMA (1997) 2.57
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol (2001) 2.45
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial. Ann Intern Med (1990) 2.40
Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA (1998) 2.36
Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 2.35
The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis (1997) 2.31
Preventive health care for adults with HIV infection. JAMA (1993) 2.29
How do medical residents discuss resuscitation with patients? J Gen Intern Med (1995) 2.20
Improving on a coin toss to predict patient adherence to medications. Ann Intern Med (2001) 2.06
Human immunodeficiency virus type 1 populations in blood and semen. J Virol (1998) 1.99
A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants. JAMA (1996) 1.97
Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis (2010) 1.97
Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study Group. Ann Intern Med (1999) 1.94
Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med (1996) 1.93
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92
Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med (1996) 1.92
Adherence: a necessity for successful HIV combination therapy. AIDS (1999) 1.91
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS (1999) 1.86
Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect (2001) 1.85
Abnormalities of central contrast sensitivity in glaucoma. Am J Ophthalmol (1979) 1.83
Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.78
The consequences of a positive prenatal HIV antibody test for women. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.74
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res (2000) 1.70
Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis (2007) 1.69
Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. Clin Infect Dis (1994) 1.68
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol (2000) 1.64
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet (2001) 1.58
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J Infect Dis (2001) 1.58
Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ (2003) 1.56
Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS (1992) 1.55
Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med (1996) 1.55
See one, do one, teach one? House staff experience discussing do-not-resuscitate orders. Arch Intern Med (1996) 1.50
Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design. Ann Intern Med (1996) 1.50
Neuropsychometric outcome following aortic arch surgery: a prospective randomized trial of retrograde cerebral perfusion. J Thorac Cardiovasc Surg (2003) 1.50
Primary HIV infection--a public health opportunity. Am J Public Health (1997) 1.44
The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav (2006) 1.44
Does HIV reporting by name deter testing? MESH Study Group. AIDS (2000) 1.43
Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis (1991) 1.43
Can a back pain screening tool help classify patients with acute pain into risk levels for chronic pain? Eur J Pain (2015) 1.42
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection. AIDS Care (2002) 1.37
Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA (1994) 1.36
Molecular epidemiology and the new tuberculosis. Infect Agents Dis (1993) 1.35
Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis (1996) 1.32
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing. J Clin Microbiol (2009) 1.32
Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance. J Clin Microbiol (1995) 1.31
Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis (2004) 1.31
Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience (1989) 1.30
Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J Biol Chem (2001) 1.30
CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. A review for clinical practitioners. Arch Intern Med (1994) 1.29
Tracking and follow-up of marginalized populations: a review. J Health Care Poor Underserved (1999) 1.29
Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver. Clin Pharmacol Ther (2013) 1.28
CT scanning and ultrasound in the evaluation of pancreatic pseudocysts: a preliminary comparison. Radiology (1978) 1.28
Caregiver burden in HIV-positive and HIV-negative partners of men with AIDS. J Consult Clin Psychol (1994) 1.27
Factors that predict bleeding following endoscopic mucosal resection of large colonic lesions. Endoscopy (2011) 1.27
Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ (1997) 1.26
Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int J Behav Med (2003) 1.24
Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med (1979) 1.23
Stress, coping, and high-risk sexual behavior. Health Psychol (1992) 1.23
Television viewing and cardiovascular risk factors in young adults: the CARDIA study. Ann Epidemiol (1996) 1.23
Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J Virol (2001) 1.23
Pilot randomized trial of education to improve self-management skills of men with symptomatic HIV/AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.23
HIV infection and injecting drug users: from epidemiology to public health. AIDS (1990) 1.21
Perseverance pays off: health care providers' impact on HIV testing decisions by adolescent females. Pediatrics (1994) 1.20
Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend (1995) 1.20
Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA (1994) 1.19
Resection of gastrinomas. Ann Surg (1983) 1.18
The relationship of type A behavior pattern to coronary heart disease. Act Nerv Super (Praha) (1980) 1.18
Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. J Infect Dis (2000) 1.17
Hostility and health behaviors in young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol (1992) 1.17
Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes. J Clin Microbiol (1994) 1.16
Pediatric renal transplants--results with sequential immunosuppression. Transplantation (1992) 1.16
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response. J Acquir Immune Defic Syndr (2000) 1.15
Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J Infect Dis (1993) 1.14
Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr (1994) 1.13
Comparative effectiveness of dried plasma HIV-1 viral load testing in Brazil using ViveST for sample collection. J Clin Virol (2010) 1.13
Smokeless tobacco cessation intervention for college athletes: results after 1 year. Am J Public Health (1999) 1.10
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment. J Acquir Immune Defic Syndr (1992) 1.09
Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer (2006) 1.09